erucin has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calderone, V; Citi, V; Di Cesare Mannelli, L; Ghelardini, C; Lazzeri, L; Martelli, A; Pagnotta, E; Piragine, E; Testai, L; Ugolini, L | 1 |
1 other study(ies) available for erucin and Pancreatic Neoplasms
| Article | Year |
|---|---|
Anticancer properties of erucin, an H
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Humans; Isothiocyanates; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Sulfides; Thiocyanates | 2019 |